Field & Main Bank Lowers Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Field & Main Bank lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.6% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 10,843 shares of the healthcare conglomerate's stock after selling 1,152 shares during the period. UnitedHealth Group makes up approximately 2.0% of Field & Main Bank's investment portfolio, making the stock its 12th largest position. Field & Main Bank's holdings in UnitedHealth Group were worth $5,679,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of UNH. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth about $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at $28,000. Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group during the fourth quarter worth about $30,000. Finally, Promus Capital LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $32,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer now directly owns 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the firm's stock in a transaction on Friday, May 16th. The shares were purchased at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the purchase, the chief executive officer now owns 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their position. The disclosure for this purchase can be found here. Insiders acquired a total of 109,408 shares of company stock worth $31,607,768 over the last 90 days. Insiders own 0.28% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on UNH shares. Barclays lowered their target price on shares of UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a research report on Monday, June 2nd. Wells Fargo & Company reissued an "overweight" rating on shares of UnitedHealth Group in a report on Friday, June 6th. Deutsche Bank Aktiengesellschaft lowered their target price on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research note on Wednesday, May 14th. TD Cowen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective on the stock. in a research report on Monday, May 19th. Finally, Truist Financial restated a "buy" rating and issued a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus price target of $427.09.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $305.59 on Wednesday. The company has a 50 day moving average price of $347.89 and a 200 day moving average price of $459.15. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a market capitalization of $277.21 billion, a price-to-earnings ratio of 12.80, a price-to-earnings-growth ratio of 1.41 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The company had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the prior year, the company earned $6.91 EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.89%. The ex-dividend date was Monday, June 16th. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.